29
Oct
2019
17:00
GMT
Webinar
The Latest Strategies To Reduce Cardiac Device Infections
-
Views:
485
-
Likes:
0
Overview
Infection of Cardiac Implantable Electronic Devices (CIEDs) such as pacemakers, ICDs and CRT devices has a high impact on a patient’s quality of life, morbidity and mortality. In addition, it is a costly burden to healthcare. New solutions are available to reduce these CIED infections; these solutions, the latest evidence and its impact on clinical practice will be presented and discussed in this webinar.
Faculty:
Mauro Biffi
Jay Wright
Christian Butter
This webinar is supported by
Key Learning Objectives
- The impact of CIED infections on the patient, the hospital and on the associated costs.
- The latest clinical evidence supporting the use of an antibacterial envelope in preventing device infections.
- How the clinical evidence can be implemented in clinical practice.
Target Audience
- Cardiologists and allied healthcare professionals involved in CIED implantation.
Faculty Biographies
Mauro Biffi
Dr Mauro Biffi is a Clinical Cardiologist and Director of Electrophysiology at Sant’Orsola-Malpighi Polyclinic, Bologna, IT. He is also a tutor at the Cardiology School of Bologna University and at several European training facilities.
His main areas of interest are arrhythmias and heart failure. Dr Biffi has participated in international clinical trials of pharmacological and non-pharmacological treatments (Dofetilide study of ventricular tachycardia suppression, B-LEFT study, ALSYNC trial, SOLVE CRT study, WRAP-IT trial, REVIVENT left ventricular reconstruction study, ADAPT-RESPONSE trial, ECG-BELT trial, ARTESIA study, ESC-EHRA EORP-AF registry and EV ICD Pivotal study).
He is focused on upstream prevention of complications associated to implantable cardiac devices therapy. Dr Biffi is the Clinical Coordinator of several multicenter studies (OPTIMIND Registry, ESSENTIAL Registry, DECODE Registry, CRT- Next randomized trial), and has co-authored more than 350 articles on indexed, peer-reviewed medical journals.
Jay Wright
Dr Jay Wright is Consultant Cardiologist, at the Liverpool Heart and Chest Hospital and he is a senior lecturer at Liverpool University and Imperial College London, United Kingdom. He is a committee member for NICOR devices survey and a council member of the British Cardio-Oncology Society (BC-OS).
Christian Butter
Prof Christian Butter is Chief of Cardiology at the Heart Center Brandenburg in Bernau/Berlin, Germany. He has a special interest in research and innovation and has pioneered several new technologies in cardiology.
Key References
1. Henrikson CA. Antibacterial Envelope Is Associated with Low Infection Rates After Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Device Replacement: Results of the Citadel and Centurion Studies. JACC Clin Electrophysiol 2017; 3(10):1158-1167.
2. Tarakji KG. Antibacterial Envelope to Prevent Cardiac Implantable Device Infection. N Engl J Med 2019; 380(20):1895-1905.